Pharmaceutical manufacturers with United States Food and Drug Administration-approved prescription drugs sold in or into Texas are required to report different types of drug pricing information to HHSC. Reporting requirements include:
- Wholesale acquisition cost (WAC) information annually;
- Drug price increase information that satisfy specific pricing criteria within 60 days of the effective date of the price increase; and,
- A manufacturer activity report
Each of these reports is subject to different reporting requirements.